Download Files:
MAX-40279 (hemifumarate)
$300 – $2,250
Products Details
Product Description
– MAX-40279 hemifumarate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1].
Web ID
– HY-145723B
Storage Temperature
– -20°C (Powder, sealed storage, away from moisture)
Shipping
– Blue Ice
Applications
– COVID-19-immunoregulation
Molecular Formula
– C22H23FN6OS.1/2C4H4O4
References
– [1]Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1.
CAS Number
– 2388506-43-0
Molecular Weight
– 554.59
Compound Purity
– 99.56
SMILES
– OC(/C=C/C(O)=O)=O.CC1=C(C2=C(C=C(C=C2)F)OC)C3=NC(NC4=CN(C5CCNCC5)N=C4)=NC=C3S1.[1/2]
Clinical Information
– Phase 2
Research Area
– Cancer; Inflammation/Immunology
Solubility
– DMF : 1.96 mg/mL (ultrasonic;warming;adjust pH to 5 with HCl;heat to 60°C)
Target
– FGFR;FLT3
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
